JMDC Inc.

Tokyo Stock Exchange 4483.T

JMDC Inc. EBIT Margin for the year ending March 31, 2024: 21.59%

JMDC Inc. EBIT Margin is 21.59% for the year ending March 31, 2024, a 2.31% change year over year. EBIT ratio is the ratio of EBIT to revenue, measuring a company's operating profitability without considering non-operating income or expenses.

JMDC Inc. EBIT Margin for the year ending March 31, 2023 was 21.10%, a -4.66% change year over year.
JMDC Inc. EBIT Margin for the year ending March 31, 2022 was 22.14%, a 0.10% change year over year.
JMDC Inc. EBIT Margin for the year ending March 31, 2021 was 22.12%, a 21.39% change year over year.
JMDC Inc. EBIT Margin for the year ending March 31, 2020 was 18.22%, a 25.67% change year over year.

Key data

Date	EBIT Margin	EPS (Basic)	EPS (Diluted)	Shares (Basic, Weighted)

Tokyo Stock Exchange: 4483.T

JMDC Inc.

CEO	Mr. Ryo Noguchi
IPO Date	Dec. 16, 2019
Location	Japan
Headquarters	Sumitomo Shiba Daimon Building
Employees	1,773
Sector	Technology
Industries Big Data Pharmaceuticals

Description

JMDC Inc. provides medical statistics data services in Japan. The company operates through three segments: Healthcare-Big Data, Telemedicine, and Dispensing Pharmacy Support. It offers medical field big data services; life insurance field big data services; support services for health insurance associations and local government health services; health data platform; and medical institution support services. The company also provides remote image interpretation matching services and ASP services for remote image interpretation system; and develops and sells business systems for dispensing pharmacies. It serves health insurance unions, pharmaceutical companies, life and non-life insurance companies, research institutions, etc. The company was incorporated in 2002 and is headquartered in Tokyo, Japan.

Key trends

Past 5 years